IMP
Process View
metanephric nephron development
The process whose specific outcome is the progression of a nephron in the metanephros over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "metanephric nephron development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.971 | Mouse | |
| PLCG1 | phospholipase C, gamma 1 | 0.897 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.715 | ||
| EGR1 | early growth response 1 | 0.664 | Human Rat | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.640 | Mouse | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.596 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.578 | ||
| EGR3 | early growth response 3 | 0.486 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.402 | Mouse Rat | |
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.368 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.329 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.317 | ||
| EGR2 | early growth response 2 | 0.202 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.185 | ||
| NKX2-1 | NK2 homeobox 1 | 0.169 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.157 | ||
| PDGFC | platelet derived growth factor C | 0.131 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.126 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.087 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.068 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.066 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.058 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.058 | ||
| FSTL1 | follistatin-like 1 | 0.047 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.042 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.042 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.040 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.036 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.035 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.033 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.029 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.026 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.020 | ||
| IER2 | immediate early response 2 | 0.020 | ||
| PTEN | phosphatase and tensin homolog | 0.020 | ||
| BMP4 | bone morphogenetic protein 4 | 0.019 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.019 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.017 | ||
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.017 | ||
| NGFR | nerve growth factor receptor | 0.015 | ||
| TCF4 | transcription factor 4 | 0.015 | ||
| KCTD1 | potassium channel tetramerisation domain containing 1 | 0.013 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.013 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.013 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.012 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.012 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.011 | ||
| CSNK1E | casein kinase 1, epsilon | 0.011 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.011 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.011 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.010 |